Capacity for clinical research on herbal medicines in Africa

Journal of Alternative and Complementary Medicine

Volumn 18, Issue 6, 2012, Pages 622-628

  Willcox, Merlin ^a   Siegfried, Nandi ^b   Johnson, Quinton ^b,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF THE WESTERN CAPE   (South Africa)

^c STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; ARTICLE; CLINICAL RESEARCH; FUNDING; GOOD CLINICAL PRACTICE; HERBAL MEDICINE; HUMAN; PATENT; PATIENT ATTITUDE; PRIORITY JOURNAL;

ADULT; AFRICA; BIOMEDICAL RESEARCH; CAPACITY BUILDING; CLINICAL TRIALS AS TOPIC; DRUG DISCOVERY; FEMALE; HERBAL MEDICINE; HUMANS; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT PREPARATIONS; PLANTS, MEDICINAL; PUBLIC HEALTH; PUBLISHING; RESEARCH PERSONNEL; YOUNG ADULT;

EID: 84864349153     PISSN: 10755535     EISSN: 15577708     Source Type: Journal    
DOI: 10.1089/acm.2011.0963     Document Type: Article

References (8)

1. Willcox ML, Bodeker G. Traditional herbal medicines for malaria. BMJ 2004;329:1156-1159. (Pubitemid 39524776)
2. Willcox M, et al. Do ethnobotanical and laboratory data predict clinical safety and efficacy of anti-malarial plants? Malaria J 2011;10(suppl 1):S7. FIG. 1. Average ratings of the importance attached to, and respondents' confidence in dealing with, different aspects of clinical trials.
3. Handema R, Terunuma H, Kasolo F. A prospective study of Agaricus blazei mycelia compound administration in asymptomatic HIV-infected patients in Lusaka, Zambia. Med J Zambia 2007;8:1-4.
4. Wambebe C, et al. Double-blind, placebo-controlled, randomised cross-over clinical trial of niprisan in patients with sickle cell disorder. Phytomedicine 2001;8:252-261. (Pubitemid 32758340)
5. Mesia K, et al. Assessment of the short-term safety and tolerability of a quantified 80% ethanol extract from the stem bark of Nauclea pobeguinii (PR 259 CT1) in healthy volunteers: A clinical phase I study. Planta Med 2011;77:111-116.
6. Kengne RDC, et al. Comparative study of the quality and efficiency of artemisinin drug based and Artemisia annua grown in Cameroon, in 5th MIM Pan-African Malaria Conference. 2009: Nairobi, Kenya:87.
7. Ogwang PE, et al. Use of Artemisia annua L. Infusion for Malaria Prevention: Mode of action and benefits in a Ugandan community. Br J Pharm Res 2011;1:124-132.
8. Wambebe CO, et al. Efficacy of niprisan in the prophylactic management of patients with sickle cell disease. Curr Ther Res 2001;62:26-34.(Pubitemid 32493028)